We are live on ! Find out more
GRTX

Galera Therapeutics, Inc. Common Stock
GRTX

Delisted

GRTX was delisted on the 3rd of June, 2024.

Back to rankings

Fund managers haven’t disclosed any holdings of GRTX yet.

GRTX Hedge Fund Activity: Q1 2026 in Review

1 of the 8,131 institutional investors tracked by Wall St. Rank reported a position in Galera Therapeutics, Inc. Common Stock (GRTX) for Q1 2026, worth a combined $4.

Buyers outnumbered sellers: 1 fund opened new GRTX positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Golden State Equity Partners, opening a new position worth an estimated $4.

  • 1 institutional investor held Galera Therapeutics, Inc. Common Stock (GRTX) as of Q1 2026, up from 0 in Q4 2025.
  • Funds reported $4 of Galera Therapeutics, Inc. Common Stock stock for Q1 2026.
  • 1 fund opened new Galera Therapeutics, Inc. Common Stock positions in Q1 2026 and 0 closed out, a net change of +1 holder.
  • The largest Galera Therapeutics, Inc. Common Stock buyer in Q1 2026 was Golden State Equity Partners, an estimated $4 added.

Based on aggregated 13F filings for Q1 2026.